Log in

NASDAQ:CHFSCHF Solutions Stock Price, Forecast & News

$0.62
+0.01 (+1.20 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.61
Now: $0.62
$0.64
50-Day Range
$0.48
MA: $0.65
$1.00
52-Week Range
$0.30
Now: $0.62
$2.92
Volume5.68 million shs
Average Volume7.06 million shs
Market Capitalization$27.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.74
CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The company's commercial product is the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, and disposable blood set and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in Brazil, Germany, Hong Kong, India, Italy, Singapore, Spain, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Read More
CHF Solutions logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.37 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CHFS
Previous SymbolNASDAQ:SSH
CUSIPN/A
Phone952-345-4200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.51 million
Book Value$0.43 per share

Profitability

Net Income$-18,110,000.00
Net Margins-285.45%

Miscellaneous

Employees55
Market Cap$27.87 million
Next Earnings Date11/3/2020 (Estimated)
OptionableNot Optionable
$0.62
+0.01 (+1.20 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHFS News and Ratings via Email

Sign-up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CHF Solutions (NASDAQ:CHFS) Frequently Asked Questions

How has CHF Solutions' stock been impacted by COVID-19?

CHF Solutions' stock was trading at $0.3125 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CHFS shares have increased by 97.8% and is now trading at $0.6180.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of CHF Solutions?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CHF Solutions in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CHF Solutions
.

When is CHF Solutions' next earnings date?

CHF Solutions is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for CHF Solutions
.

How were CHF Solutions' earnings last quarter?

CHF Solutions Inc (NASDAQ:CHFS) released its earnings results on Tuesday, August, 4th. The company reported ($0.10) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.19) by $0.09. CHF Solutions had a negative return on equity of 295.29% and a negative net margin of 285.45%.
View CHF Solutions' earnings history
.

When did CHF Solutions' stock split? How did CHF Solutions' stock split work?

CHF Solutions's stock reverse split on Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of CHF Solutions stock prior to the reverse split would have 5 shares after the split.

What price target have analysts set for CHFS?

1 brokers have issued 1 year price objectives for CHF Solutions' shares. Their forecasts range from $1.50 to $1.50. On average, they anticipate CHF Solutions' stock price to reach $1.50 in the next year. This suggests a possible upside of 142.7% from the stock's current price.
View analysts' price targets for CHF Solutions
.

Has CHF Solutions been receiving favorable news coverage?

News headlines about CHFS stock have trended negative recently, according to InfoTrie. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CHF Solutions earned a news sentiment score of -2.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term.
View the latest news about CHF Solutions
.

Are investors shorting CHF Solutions?

CHF Solutions saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 1,240,000 shares, an increase of 85.6% from the June 15th total of 668,200 shares. Based on an average daily volume of 7,640,000 shares, the days-to-cover ratio is presently 0.2 days.
View CHF Solutions' Short Interest
.

Who are some of CHF Solutions' key competitors?

What other stocks do shareholders of CHF Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CHF Solutions investors own include IMMUTEP LTD/S (IMMP), Tonix Pharmaceuticals (TNXP), Biocept (BIOC), Onconova Therapeutics (ONTX), T2 Biosystems (TTOO), Avinger (AVGR), Ibio (IBIO), Zosano Pharma (ZSAN), Superconductor Technologies (SCON) and Heat Biologics (HTBX).

Who are CHF Solutions' key executives?

CHF Solutions' management team includes the following people:
  • Mr. John L. Erb, Chairman, CEO & Pres (Age 70)
  • Ms. Claudia Napal Drayton, Chief Financial Officer (Age 51)
  • Mr. Vitaliy Epshteyn, Sr. VP of Operations & Engineering (Age 41)
  • Mr. David Lerner, Sr. VP of Corp. Devel. & Technology
  • Mr. Thomas P. Lynch, VP, Gen. Counsel, Chief Compliance Officer & Sec. (Age 52)

What is CHF Solutions' stock symbol?

CHF Solutions trades on the NASDAQ under the ticker symbol "CHFS."

Who are CHF Solutions' major shareholders?

CHF Solutions' stock is owned by a variety of retail and institutional investors. Top institutional investors include UBS Group AG (0.23%).
View institutional ownership trends for CHF Solutions
.

Which major investors are buying CHF Solutions stock?

CHFS stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG.
View insider buying and selling activity for CHF Solutions
.

How do I buy shares of CHF Solutions?

Shares of CHFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CHF Solutions' stock price today?

One share of CHFS stock can currently be purchased for approximately $0.62.

How big of a company is CHF Solutions?

CHF Solutions has a market capitalization of $27.87 million and generates $5.51 million in revenue each year. The company earns $-18,110,000.00 in net income (profit) each year or ($9.30) on an earnings per share basis. CHF Solutions employs 55 workers across the globe.

What is CHF Solutions' official website?

The official website for CHF Solutions is www.chf-solutions.com.

How can I contact CHF Solutions?

CHF Solutions' mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company can be reached via phone at 952-345-4200 or via email at [email protected]hf-solutions.com.

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.